<DOC>
	<DOCNO>NCT00552448</DOCNO>
	<brief_summary>Asthma disease result mucus hypersecretion airway obstruction . This cause difficulty breathe . The High Frequency Chest Compressor ( HFCC ) device show decrease respiratory complication individual severe disability unable clear airway secretion . There lack study use device child asthma . The device show study safe child asthma . The investigator propose use device pediatric patient hospitalize pediatric ICU asthma result decrease pediatric ICU stay . The investigator also look asthma severity , total day hospital stay chest discomfort therapy .</brief_summary>
	<brief_title>Use High Frequency Chest Compression Pediatric Status Asthmaticus</brief_title>
	<detailed_description>Background : Asthma third large cause hospitalization child 15 year age . It reversible obstructive lung disease cause airway inflammation constriction airway smooth muscle . Mucus produce gland airway become enlarged result overproduction mucus . All factor result airflow obstruction airtrapping , ventilation/perfusion mismatch hypoxia . Therapies beta-agonists ( i.e . albuterol ) , anti-cholinergics ( i.e . atrovent ) steroid use acute asthma attack . Unfortunately , patient may develop status asthmaticus , severe attack respond nebulized bronchodilator , require intensive care admission . HFCC FDA ( 1988 Class II 510K ) approve device/modality chest physiotherapy utilized patient mucus hypersecretion , atelectasis pneumonia . There paucity pediatric study . A comparative retrospective/prospective data analysis exacerbation hospitalization medically fragile ( profoundly disable ) child use outpatient HFCC show use therapy reduce day hospitalization pulmonary exacerbation . Long term use quadriplegic child reduce pulmonary secretion , incidence pneumonia , number hospitalization . In pediatric cystic fibrosis population , improvement lung function hospitalization long term decrease progression lung disease . Furthermore , patient mild moderate asthma , decline lung function use beta agonist HFCC versus beta agonist alone indicate good tolerance safety . Because asthma patient mucus hypersecretion modality show effective patient population mucus hypersecretion , modality use mean reduce pulmonary morbidity thereby allow respiratory therapist allocate his/her time efficiently . Purpose : Assess efficacy HFCC PICU population age 2 21 year age status asthmaticus Design : Prospective Randomized non blind HFCC ( administer 4 time day 20 minute ) conventional PICU management asthma exacerbation vs. conventional PICU management asthma exacerbation alone . Child would standard asthma medication change stop study . End Points Interest : Primary 1 ) PICU day - Average number PICU day research 4.47 day . There may factor non PICU floor availability PICU round may delay transfer PICU non PICU floor . So official discharge PICU attend PICU physician announces deem acceptable PICU discharge Secondary 1 . Length hospitalization 2 . Pediatric Asthma Severity Score validate asthma severity score pediatric population : 1 ) observe level respiratory distress 2 ) accessory muscle use 3 ) auscultation ( degree wheezing ) 4 ) oxygen saturation 5 ) respiratory rate Scored observation 0 , 1 , 2 total observation number Severity score 3 . Discomfort Patient inclusion 2 21 yo ( VEST approve two yo ) Admitted PICU status asthmaticus Negative urine pregnancy test prior initiation study menses Patient Exclusion Absolute contraindication VEST use : 1 . Unstable head neck injury 2 . Active hemorrhage hemodynamic instability 3 . Intracranial pressure &gt; 20 mmHg intracranial pressure avoid ( relative contraindication discussion move absolute ) Presence anomaly : 1 . Former premature infant BPD 2 . Congenital bronchogenic pulmonary anomaly ( i.e . CF ) 3 . Congenital heart disease</detailed_description>
	<mesh_term>Status Asthmaticus</mesh_term>
	<criteria>2 21 yo ( VEST approve two yo ) Admitted PICU status asthmaticus Negative urine pregnancy test prior initiation study menses Absolute contraindication VEST use : 1 . Unstable head neck injury 2 . Active hemorrhage hemodynamic instability 3 . Intracranial pressure &gt; 20 mmHg intracranial pressure avoid ( relative contraindication discussion move absolute ) Presence anomaly : 1 . Former premature infant BPD 2 . Congenital bronchogenic pulmonary anomaly ( i.e . CF ) 3 . Congenital heart disease</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Pediatric , asthma , pediatric ICU</keyword>
</DOC>